Patents Assigned to Sanos Bioscience A/S
  • Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
    Patent number: 7371721
    Abstract: The present invention relates to methods for prevention and treatment of bone-related disorders and calcium homeostasis related syndromes using a GLP-2 molecule or GLP-2 activator either alone or in combination with another therapeutic. The present invention also encompasses methods of diagnosing or monitoring the progression of a disorder. The invention also encompasses methods of monitoring the effectiveness of treatment of the invention.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: May 13, 2008
    Assignee: Sanos Bioscience A/S
    Inventors: Dennis Bang Henriksen, Jens Juul Holst
  • Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
    Patent number: 7186683
    Abstract: The present invention relates to methods for prevention and treatment of bone-related or nutrition-related disorders using a GLP molecule or GLP activator either alone or in combination with another therapeutic. The present invention also encompasses methods of diagnosing or monitoring the progression of a disorder. The invention also encompasses methods of monitoring the effectiveness of treatment of the invention.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: March 6, 2007
    Assignee: Sanos Bioscience A/S
    Inventors: Dennis B. Henriksen, Jens J. Holst
  • Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds
    Patent number: 6943151
    Abstract: Disclosed are methods of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related Compounds. The invention has a wide spectrum of important uses including hyperparathyroidism, Paget's disease, hypercalcemia of malignancy, osteolytic lesions produced by bone metastasis, bone loss due to immobilisation or sex hormone deficiency, osteomalacia, hyperostosis and osteopetrosis.
    Type: Grant
    Filed: March 18, 2003
    Date of Patent: September 13, 2005
    Assignee: Sanos Bioscience A/S
    Inventors: Dennis B. Henriksen, Jens J. Holst
  • Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
    Patent number: 6770620
    Abstract: The present invention relates to methods for prevention and treatment of bone-related or nutrition-related disorders using a GLP molecule or GLP activator either alone or in combination with another therapeutic. The present invention also encompasses methods of diagnosing or monitoring the progression of a disorder. The invention also encompasses methods of monitoring the effectiveness of treatment of the invention.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: August 3, 2004
    Assignee: Sanos Bioscience A/S
    Inventor: Dennis Bang Henriksen